{
    "clinical_study": {
        "@rank": "1504", 
        "arm_group": [
            {
                "arm_group_label": "Minoxidil lotion 1%", 
                "arm_group_type": "Experimental", 
                "description": "Minoxidil lotion 1% is applied twice daily to one eyebrow."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo is applied twice daily to the other eyebrow."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to compare efficacy and safety of minoxidil 1% versus placebo in\n      enhancement of eyebrows."
        }, 
        "brief_title": "Minoxidil 1% for Eyebrow Enhancement", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Eyebrow Hypotrichosis", 
            "Thin Eyebrow"
        ], 
        "condition_browse": {
            "mesh_term": "Hypotrichosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  male or female aged 18-60 years\n\n          -  hypotrichosis of eyebrows\n\n          -  healthy\n\n          -  informed consent obtained\n\n        Exclusion Criteria:\n\n          -  underlying diseases\n\n          -  alopecia areata or trichotillomania\n\n          -  thyroid diseases\n\n          -  pregnancy or breast feeding\n\n          -  previous eyebrow tattoo, trauma or accident.\n\n          -  history of eyebrow or hair medications in 6 months\n\n          -  history of minoxidil or its ingredient allergy\n\n          -  history of eyebrow surgery."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01924000", 
            "org_study_id": "REH-56059"
        }, 
        "intervention": [
            {
                "arm_group_label": "Minoxidil lotion 1%", 
                "description": "Minoxidil lotion 1% is applied twice daily to one eyebrow.", 
                "intervention_name": "Minoxidil lotion 1%", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Placebo is applied twice daily on the other eyebrow."
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Minoxidil"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 20, 2014", 
        "link": {
            "url": "http://www.mfu.ac.th/2012eng/"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand"
                }, 
                "name": "Mae Fah Luang University Hospital (Bangkok)"
            }
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "2", 
        "official_title": "Minoxidil 1% for Eyebrow Enhancement: A Randomized , Double-blind , Placebo-controlled , Split-face Comparative Study", 
        "other_outcome": [
            {
                "measure": "The change in number of hairs after 16 weeks from baseline", 
                "safety_issue": "No", 
                "time_frame": "baseline and 16 weeks"
            }, 
            {
                "measure": "Number of participants with adverse events. Adverse events include any skin rashes or symptoms.", 
                "safety_issue": "Yes", 
                "time_frame": "16 weeks"
            }, 
            {
                "measure": "Patient satisfaction by self-assessment questionnaires", 
                "safety_issue": "No", 
                "time_frame": "baseline and 16 weeks"
            }
        ], 
        "overall_official": {
            "affiliation": "Mae Fah Luang University Hospital (Bangkok)", 
            "last_name": "Chuchai Tanglertsampan, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Thailand: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The change of global photographic assessment after 16 weeks from baseline", 
            "safety_issue": "No", 
            "time_frame": "baseline and 16 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01924000"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mae Fah Luang University Hospital", 
            "investigator_full_name": "Chuchai TANGLERTSAMPAN, MD", 
            "investigator_title": "Instructor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "22594928", 
            "citation": "Suwanchatchai W, Tanglertsampan C, Pengsalae N, Makornwattana M. Efficacy and safety of bimatoprost 0.03% versus minoxidil 3% in enhancement of eyebrows: a randomized, double-blind, split-face comparative study. J Dermatol. 2012 Oct;39(10):865-6. doi: 10.1111/j.1346-8138.2012.01579.x. Epub 2012 May 17."
        }, 
        "secondary_outcome": {
            "measure": "The change of hair diameter after 16 weeks from baseline", 
            "safety_issue": "No", 
            "time_frame": "baseline and 16 weeks"
        }, 
        "source": "Mae Fah Luang University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mae Fah Luang University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}